CML is a clonal neoplastic disorder of hematopoietic stem cells caused by expression of the chimeric BCR/ABL fusion oncogene (abnormality occurs in more than 95% patients) [119]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.